atorvastatin [orch, phsu]
Bezafibrate [orch, phsu]
Mixed hyperlipidaemia [dsyn]
Clinical Trial [resa]
Efficacy [qlco]
Safety [hcpp]
Study [mnob]
Objective [inpr]
Combined hyperlipidemia NOS [dsyn]
Highly [qlco]
Atherogenesis [patf]
Lipid [lipd]
Phenotype [orga]
Abnormalities, Multiple [cgab]
Lipoprotein [aapp, bacs]
Difficult [qlco]
Normalize [resa]
Single [popg]
Drug Therapy [topp]
Controlled Clinical Trial [inpr]
Compared [acty]
Efficacy [qlco]
Safety [hcpp]
atorvastatin [orch, phsu]
Bezafibrate [orch, phsu]
Patients [podg]
Diet [food]
Resistant [ftcn]
Combined hyperlipidemia NOS [dsyn]
Patients [podg]
Study Design [resa]
Following [tmco]
placebo [topp]
Run-in Period [tmco]
Patients [podg]
Received [qlco]
atorvastatin [orch, phsu]
Bezafibrate [orch, phsu]
Once daily [tmco]
DOUBLE BLIND [resa]
placebo-controlled [resa]
Trial [resa]
Meet [idcn]
Low Density Lipoprotein Cholesterol [bacs, strd]
Target [ftcn]
atorvastatin [orch, phsu]
Dosages [qnco]
Increased [qnco]
Once daily [tmco]
weeks [tmco]
weeks [tmco]
atorvastatin [orch, phsu]
reductions [npop]
Bezafibrate [orch, phsu]
Percentage [qnco]
Decrease [qlco]
P NOS [aapp, imft]
Bezafibrate [orch, phsu]
reductions [npop]
Triglyceride [bacs, lipd]
atorvastatin [orch, phsu]
Percentage [qnco]
Decrease [qlco]
P NOS [aapp, imft]
increases [ftcn]
High Density Lipoprotein Cholesterol [bacs, lipd]
Percentage [qnco]
P NOS [aapp, imft]
Target [ftcn]
Global [spco]
atorvastatin [orch, phsu]
Recipient [humn]
Bezafibrate [orch, phsu]
Recipient [humn]
Triglyceride level [lbtr]
mg dl [qnco]
Patients [podg]
Patients [podg]
Normal [qlco]
baseline [bodm]
High Density Lipoprotein Cholesterol [bacs, lipd]
Bezafibrate [orch, phsu]
Superior [spco]
atorvastatin [orch, phsu]
High Density Lipoprotein Cholesterol [bacs, lipd]
With [qlco]
baseline [bodm]
High Density Lipoprotein Cholesterol [bacs, lipd]
mg dl [qnco]
Drugs [phsu]
Raised [qnco]
High Density Lipoprotein Cholesterol [bacs, lipd]
Extent [spco]
Adjustment [inbe]
baseline [bodm]
Values [qlco]
Drugs [phsu]
Well [qlco]
atorvastatin [orch, phsu]
Efficacy [qlco]
Bezafibrate [orch, phsu]
Reaching [orgf]
Triglyceride level [lbtr]
Target [ftcn]
Combined hyperlipidemia NOS [dsyn]
Support [medd]
Patients [podg]
Lipid [lipd]
Phenotype [orga]
